Cargando…
Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug
Lung cancer (LC) is one of the leading causes of high cancer-associated mortality worldwide. Non-small cell lung cancer (NSCLC) is the most common type of LC. The mechanisms of NSCLC evolution involve the alterations of multiple complex signaling pathways. Even with advances in biological understand...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512551/ https://www.ncbi.nlm.nih.gov/pubmed/37744063 http://dx.doi.org/10.3389/fchem.2023.1251986 |